Positron Emission Tomography And Recovery following Revascularization: A Multi Centre, Randomized Trial of Evaluation of Outcome and Cost-Effectiveness using an F-18-fluorodeoxyglucose (FDG) PET-Guided Approach to Management of Patients with Coronary Disease and Severe LV Dysfunction (PARR Phase 2)

niversity of Ottawa Heart Institute (Canada)0 个研究点目标入组 430 人开始时间: 2007年10月22日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Age greater than or equal to 18 years, either sex
•2. Coronary artery disease documented by coronary angiography, previous myocardial infarction (MI), previous revascularization procedure or positive exercise stress/perfusion imaging
•3. Severely reduced LV function with ejection fraction (EF) less than or equal to 35% attributable to coronary disease
•4. Any patient being considered for revascularization, transplant/heart failure work up or where in the opinion of the attending physician viability imaging would be considered useful in the ongoing clinical managements

•1. Co-morbid medical conditions likely to make survival for the duration of the study unlikely
•2. Less than four weeks post MI
•3. Not suitable for revascularization before randomization
•4. Patients requiring emergency revascularization
•5. Lack of informed consent

发起方

niversity of Ottawa Heart Institute (Canada)